Hematology and Oncology

Home Hematology and Oncology
Despite adequate levels of prescriber

Inappropriate Use of Fentanyl Preps Seen Despite Awareness

Claims data show many prescribed transmucosal immediate-release fentanyl were opioid-nontolerant
The use of plasma infusion therapies (often called "vampire" treatments

FDA Warns About ‘Miracle’ Young Blood Infusion Treatments

Expensive 'fountain of youth' therapies are unproven, potentially harmful
The multigene expression test Oncotype DX is not cost-effective for women with breast cancer who are at low risk for recurrence

Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer

Incremental cost-effectiveness ratio varies across clinical risk groups, sensitive to patient age
Metastasis-free survival is significantly longer among men with nonmetastatic

Darolutamide Slows Spread of Castration-Resistant Prostate Cancer

Significant survival benefit seen, adverse events similar between darolutamide and placebo

Risk Factors ID’d for Diffuse Large B-Cell Lymphoma Mortality

In older patients, risk factors include advanced age, DLBCL stage, Charlson Comorbidity Index
Artificial intelligence software can predict prognosis in epithelial ovarian cancer above established prognostic methods

Artificial Intelligence Predicts Survival in Epithelial Ovarian Cancer

Radiomic Prognostic Vector IDs patients with median overall survival of less than two years
Growth in hospital prices and payments outpaced growth in physician prices and payments from 2007 through 2014

Hospital Prices Growing Faster Than Physician Prices

Efforts to reduce health care spending should focus on hospital prices
People with a wide variety of chronic diseases are less physically active than individuals without chronic diseases

Physical Activity Down Across Chronic Disease Subgroups

Mental health disorders tied to lowest moderate activity; those with CVD have lowest vigorous activity

p, p’-DDT Exposure Linked to Breast Cancer Through Age 54

Risk for breast cancer varies based on timing of first exposure, age at diagnosis
Dialysis and kidney transplant patients have more than a 2.5-fold increased risk for cancer death

Cancer Death Risk Up for Kidney Transplant, Dialysis Patients

Risk mainly due to preexisting cancers in dialysis patients, de novo cancers in transplant recipients